Nexstim Plc Depression Therapy Business Update
All of the current NBT® systems in the US have been installed on a pay-per-use leasing model meaning that the majority of the NBT® therapy revenue from these systems will be recognized as net sales during year 2019. In the US, Nexstim is targeting an annual revenue level of about US$ 100 thousand per installed NBT® system. The European TMS markets are more varied and less developed than the US. As a result, Nexstim has adopted different targeted revenue models, which take into account the mix of private and public payors in each of the countries it operates.
More info on Nexstim's website.
Previous > Capricorn Venture Partners holds final close of its Capricorn Sustainable Chemistry Fund at € 86.5 million adding new investors